A Retrospective Study Evaluating Collection Efficiency Of Pre-Emptive Plerixafor Administration (P-PL) Versus Standard Plerixafor Administration (S-PL) In Patients With Myeloma Undergoing Stem Cell Mobilization.
Phase of Trial: Phase IV
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Plerixafor (Primary)
- Indications Myeloma; Stem cell mobilisation
- Focus Therapeutic Use
- 20 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.